Skip to main content
. Author manuscript; available in PMC: 2021 Dec 15.
Published in final edited form as: Clin Genet. 2021 Apr 21;100(2):119–131. doi: 10.1111/cge.13966

TABLE 3.

Cancer screening outcome stratified by P/LP, VUS, and B/LB genetic test results

Breast P/LP (%) VUS (%) B/LB (%)
Conley 202017 (mammogram) 90.0 90.0 94.8
Garcia 201420 (mammogram) 7.0 26.5 NA
Conley 202017 (breast MRI) 30.0 33.3 32.8
Garcia 201420 (breast MRI) 3.0 3.0 NA
Hamilton 201921 (breast MRI) 50.0 69.2 NA
Hamilton 201921 (other) 62.5 56.1 NA
Ovarian
Conley 202017 (CA-125) 25.0 7.1 11.0
Garcia 201420 (CA-125) 2.0 16.2 NA
Conley 202017 (TVUS) 56.2 38.1 26.8
Garcia 201420 (TVUS) 2.3 17.5 NA
Colorectal
Chang 201916 (colonoscopy) 4.5 8.9 9.8

Note: % refers to the proportion of participants who underwent screening.

Abbreviations: B/LB, benign or likely benign; CA-125: cancer antigen-125; P/LP, pathogenic or likely pathogenic; TVUS: transvaginal ultrasound; VUS: variant of uncertain significance.